Results 231 to 240 of about 14,599 (248)

Allergen specific immunotherapy for atopic dermatitis

Current Opinion in Allergy & Clinical Immunology, 2007
To describe recent developments as well as the pros and cons of allergen specific immunotherapy as a putative therapeutic option for a subgroup of patients with atopic dermatitis.The question whether specific immunotherapy would impair or improve the severity and course of atopic dermatitis has been a matter of debate for a long time.
openaire   +2 more sources

Allergen-Specific Immunotherapy with Recombinant Allergens

2011
Subcutaneous immunotherapy is a well-documented treatment of allergic rhinitis and asthma. The major limitation is the risk of anaphylactic side effects. The documentation of clinical efficacy is based on crude allergenic extracts sometimes containing varying amounts of individual allergens including allergens to which the patient may not be sensitized.
G, Pauli, Hans-Jørgen, Malling
openaire   +2 more sources

Allergen-specific immunotherapy in childhood asthma

Current Opinion in Pediatrics, 1997
Immunotherapy has been shown to prevent rhinitis symptoms in seasonal allergic rhinitis, and to prevent anaphylaxis to hymenoptera and fire ant stings. The evidence supporting its effectiveness in the treatment of asthma is much more limited; it appears that clinical trials, until the past year, have only tested therapy for single allergens such as ...
openaire   +2 more sources

Mechanisms of allergen-specific immunotherapy

Folia Pharmacologica Japonica
Allergen-specific immunotherapy (AIT) has been a longstanding treatment for allergic diseases. Historically, subcutaneous immunotherapy was the main approach, but with the development of sublingual preparations, which are associated with fewer systemic side effects, sublingual immunotherapy is gaining global popularity.
openaire   +2 more sources

Allergen-specific immunotherapy in allergic rhinitis

Current Opinion in Allergy and Clinical Immunology, 2001
The scope of this review is to highlight important and interesting articles in the field of allergen-specific immunotherapy in allergic rhinitis published within the past year. The review is not intended to give a full overview of published literature but rather to focus on some subjects that I find significant in relation to the understanding of the ...
openaire   +2 more sources

[Intralymphatic allergen-specific immunotherapy].

Ugeskrift for laeger, 2019
An emerging method for allergen-specific immunotherapy is intralymphatic placement, which only requires three injections with intervals of four weeks. In this review, we summarise available evidence on clinical safety, biological efficacy and therapeutic outcomes. The treatment appears to be safe with only few and mild adverse reactions.
Sara Haunstrup, Næraa, Niels-Erik Harbo, Schollert, Peter Nytofte, Flader Skov, Preben, Homøe   +3 more
openaire   +1 more source

[Allergen-specific immunotherapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2021
R, Treudler, W, Pfützner
openaire   +1 more source

Allergen-specific immunotherapy

2012
Hans-Jørgen Malling, Jonathan Corren, Peter S Creticos   +2 more
openaire   +1 more source

Allergen-specific Immunotherapy

2017
Anthony J. Frew, Helen E. Smith
openaire   +1 more source

Allergen-Specific Immunotherapy

2002
A Kay, Mark Larché
openaire   +1 more source